| Bayer (Schweiz) AG - Eylea, 2 mg/0,05 ml, Injektionslösung in Durchstechflasche | | 62397 | | 01 | | Eylea, 2 mg/0,05 ml | | Injektionslösung in Durchstechflasche | | S01LA05 | | Aflibercept | | 29.10.2012 | | |
| | Composition | | afliberceptum 2 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, natrii chloridum, saccharum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.05 ml corresp. natrium 60 µg. | | Packungsbestandteile | | Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Afliberceptum | 2mg / 0.05ml |
| | BAG: Active Agent | Dose |
|---|
| Afliberceptum | 2 mg |
| | | | Inactive agents |
|---|
| Disodium Phosphate Heptahydrate | | Sodium Chloride | | Sodium Dihydrogenophosphate Monohydrate | | Polysorbatum 20 | | Saccharum |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | Durchstechflasche(n) | 500.00 | 563.25 | B | SL | No |
|
|
